This Biotech Fund Sold $8 Million, Yet Remains Bullish on Terns
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Recognize the warning signs of a bad investment to protect your finances. Stay informed and make sound investment decisions.
18,560 articlesA biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
A new PWBM study places the insolvency deadline for Social Security's trust fund at 2032, six years from now. It eval...
MSFO continues to pay weekly distributions despite a sharp stock slide in Microsoft. As MSFT falls, MSFO investors we...
The renewable energy megatrend isn’t a quick flip. This guide spotlights three resilient stocks to own for decades, w...
A respected Wall Street voice argues for a bold bitcoin target. This guide breaks down the reasoning, checks the math...
Epic Games cuts 1,000 jobs as Fortnite engagement wanes in a challenging market. The move highlights how live-service...
When a chief financial officer sells a sizable chunk of stock, it draws attention. This article breaks down the impli...
A bold shift in AI strategy rewrite the investment thesis around Alphabet. OpenAI exits the AI video space, creating ...
If you’ve got $5,000 to invest, these three AI-driven stock picks offer a balanced blend of growth potential and prac...
The moment the invest paperback arrives! in your mailbox signals more than a fresh read. It’s a chance to build a pra...
Snowflake stock down hard has sparked headlines and worries about growth. But the core platform—cross‑cloud data ware...
As Progyny gears up for 2026, investors want clarity on what drives progyny (pgny) 2026 earnings. This guide breaks d...